Merck & Co.’s blockbuster cancer drug Keytruda has risen in price to $210,000 for one year’s treatment under President Donald Trump — a 6% increase since last year, a new Senate report found. The pharmaceutical giant is among more than a dozen companies that signed confidential deals with the Trump administration to lower the prices…
Just days before Christmas 2025, leaders of nine pharmaceutical companies clustered in the Roosevelt Room of the White House, where Teddy Roosevelt’s 1906 Nobel Peace Prize once hung. Photographers flocked for pictures as the executives, three women and six men, stood awkwardly, tapping their feet and drumming their fingers while waiting for President Donald Trump….
If you’re wondering what effect Intel’s blockbuster deal with Nvidia will have on its existing product roadmaps, Intel has one message for you: it won’t. “We’re not discussing specific roadmaps at this time, but the collaboration is complementary to Intel’s roadmap and Intel will continue to have GPU product offerings,” an Intel spokesman told my…
